Skip to search formSkip to main contentSkip to account menu

irtemazole

Known as: 1H-Benzimidazole, 5-(1H-imidazol-1-ylphenylmethyl)-2-methyl-, (+-)-, 5-((1H-imidazol-1-yl)phenylmethyl)-2-methyl-1H-benzimidazole 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
La presente invention concerne des composes 2-(pyrazol-1-yl)-benzimidazole substitues de formule generale (I) : dans laquelleR 2… 
2006
2006
Using carbodiimide reagents [1,3-diisopropylcarbodiimide or N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC… 
2006
2006
SummaryIrtemazole 12.5 to 50 mg in 6 healthy, normouricaemic subjects caused a maximal decrease in plasma uric acid (after 8 to… 
1989
1989
A single oral dose of 50 mg irtemazole exhibited a clear cut uricosuric effect in five patients with hyperuricemia and normal… 
1989
1989
SummaryFollowing a single dose of 50 mg irtemazole per os, plasma uric acid levels decreased after 1 h and fell to 53.5% of the… 
1989
1989
5 [( 1Himidazol1 yl)phenylmethyl] 2methyl 1tt benzimid azole (C18H16N4; generic name: irtemazole) has been tested for its… 
1975
1975
Benzimidazoles are weak mutagens acting through base substitutions; they are incorporated into nucleic acids. Experiments with…